--- title: "What Teradyne (TER)'s Launch of Next-Gen HBM Memory Tester Means For Shareholders" description: "Teradyne has launched the Magnum 7H, a next-gen memory tester aimed at high bandwidth memory devices for AI and cloud infrastructure. This advancement positions Teradyne to meet rising demand in the s" type: "news" locale: "en" url: "https://longbridge.com/en/news/252386168.md" published_at: "2025-08-10T16:25:47.000Z" --- # What Teradyne (TER)'s Launch of Next-Gen HBM Memory Tester Means For Shareholders > Teradyne has launched the Magnum 7H, a next-gen memory tester aimed at high bandwidth memory devices for AI and cloud infrastructure. This advancement positions Teradyne to meet rising demand in the semiconductor industry. The company anticipates third-quarter revenue between $710 million and $770 million, with a long-term outlook of $4.1 billion in revenue by 2028. However, uncertainties in customer spending and macroeconomic factors pose risks. Fair value estimates for Teradyne's stock range from $91.14 to $126.95, indicating potential upside but also caution due to fluctuating demand. - Earlier this month, Teradyne unveiled the Magnum 7H, a next-generation memory tester designed to address the complex testing requirements of high bandwidth memory devices used in generative AI and cloud infrastructure, with shipments already ramping at major HBM manufacturers. - This launch marks a significant advancement for Teradyne, positioning the company to meet increasing demand for robust, efficient testing solutions as AI and high-performance computing technologies evolve. - We'll examine how Teradyne’s expansion into advanced HBM testing tools may influence its investment narrative and future growth drivers. The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 20 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement. ## Teradyne Investment Narrative Recap To be a Teradyne shareholder today, you likely need conviction in the continued growth of AI, semiconductors, and automation, and confidence that the company's expanding test offerings, such as the new Magnum 7H, will sustain relevance as next-generation computing unfolds. This product launch may reinforce Teradyne’s role as a supplier for leading-edge HBM manufacturing, which could positively influence near-term industry demand, yet uncertainties in customer spending and demand visibility, particularly beyond the second quarter, remain the biggest wildcard. In the short term, while Magnum 7H addresses an important technological shift, the primary near-term business risk, fluctuating demand, driven by external macro and geopolitical factors, has not fundamentally changed. Among recent announcements, Teradyne’s updated third-quarter guidance stands out: the company expects revenue between US$710 million and US$770 million, with GAAP net income of US$0.62 to US$0.80 per diluted share. This guidance will now be measured against the potential impact of new HBM test solutions, as demand for advanced AI and semiconductor infrastructure evolves. But even as new products roll out, investors should keep an eye on... Read the full narrative on Teradyne (it's free!) Teradyne's outlook anticipates $4.1 billion in revenue and $972.1 million in earnings by 2028. This reflects a 13.2% annual revenue growth rate and an earnings increase of $502.9 million from the current $469.2 million. Uncover how Teradyne's forecasts yield a $114.50 fair value, a 7% upside to its current price. ## Exploring Other Perspectives Fair value estimates from six Simply Wall St Community members range from US$91.14 to US$126.95 per share. With demand visibility limited by global economic factors, you’ll find a variety of opinions, explore these views to see how your outlook compares. Explore 6 other fair value estimates on Teradyne - why the stock might be worth 15% less than the current price! ## Build Your Own Teradyne Narrative Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd. - A great starting point for your Teradyne research is our analysis highlighting 1 key reward that could impact your investment decision. - Our free Teradyne research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Teradyne's overall financial health at a glance. ## No Opportunity In Teradyne? Early movers are already taking notice. See the stocks they're targeting before they've flown the coop: - The end of cancer? These 26 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's. - Uncover the next big thing with financially sound penny stocks that balance risk and reward. - AI is about to change healthcare. These 24 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. *This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.* ### Related Stocks - [TER.US - Teradyne](https://longbridge.com/en/quote/TER.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Oppenheimer & Co. Inc. 增加了在泰瑞達公司（Teradyne, Inc.）的持倉 $TER | Oppenheimer & Co. Inc. 在第三季度將其在泰瑞達（Teradyne, Inc.）的持股增加了 187.3%，在收購了額外的 30,812 股後，持有 47,266 股。該持股的估值為 650 萬美元。其他對沖基金也調整了 | [Link](https://longbridge.com/en/news/275595809.md) | | 看看大户們如何操作泰瑞達 | 投資者對泰瑞達（NASDAQ:TER）表現出樂觀情緒，顯著的期權交易活動被記錄下來。共跟蹤了 15 筆期權交易，顯示出 46% 的看漲情緒和 20% 的看跌情緒。主要市場動向集中在 40.0 美元到 320.0 美元的價格區間。目前，TER | [Link](https://longbridge.com/en/news/275625924.md) | | 索羅斯逆市加碼微軟及 Nvidia 等科企 新買入黃金股 清倉 4 隻股份 | 索羅斯基金管理公司在 2022 年第四季度加大對微軟、英偉達和蘋果等大型科技股的投資，同時增持黃金股以對衝風險。基金還增持了 Atlassian、Salesforce 和 Uber 等軟體公司股票，但大幅減持了 Snowflake 和 Ci | [Link](https://longbridge.com/en/news/275990619.md) | | 美國 1 月 CPI 來襲！標普 500、輝達、德國 DAX 指數、澳元/美元技術分析 | 美國勞工統計局將於 2 月 13 日發布 1 月消費者價格指數（CPI），預計服務價格漲幅放緩將導致通脹降温，但核心通脹率可能上升。1 月非農就業數據強勁，促使市場對美聯儲降息次數的預期減少。標普 500 指數在 2 月 12 日下跌 1. | [Link](https://longbridge.com/en/news/275974381.md) | | 永泰地產與資本策略中環地標項目「 Central Crossing」結構平頂完工 預計今年年中落成 | 永泰地產有限公司與資本策略地產有限公司聯合宣佈，位於中環的旗艦項目 Central Crossing 已完成結構平頂工程，預計於今年中旬落成。該項目是香港首個集甲級寫字樓、國際奢華酒店、零售購物村及綠化公共空間於一體的綜合發展，面積約 43 | [Link](https://longbridge.com/en/news/275705950.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.